Cosmo Chemical Co., Ltd. (005420.KS)
KRW 16020.0
(-4.13%)
KRW 16020.0
(-4.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 798.98 Billion | 718.19 Billion | 512.61 Billion | 355.5 Billion | 406.82 Billion | 678.09 Billion |
| Cost of Revenue | 754.41 Billion | 637.44 Billion | 448.34 Billion | 320.55 Billion | 382.71 Billion | 641.96 Billion |
| Gross Profit | 44.56 Billion | 80.74 Billion | 64.26 Billion | 34.94 Billion | 24.11 Billion | 36.12 Billion |
| Operating Expenses | 43.56 Billion | 39.31 Billion | 33.78 Billion | 29.81 Billion | 29.33 Billion | 29.17 Billion |
| Selling, General and Administrative Expenses | 18.31 Billion | 16.62 Billion | 13.72 Billion | 10.03 Billion | 11.1 Billion | 14.03 Billion |
| Research and Development Expenses | 3.77 Billion | 3.45 Billion | 3.33 Billion | 3.86 Billion | 3.82 Billion | 3.08 Billion |
| Other Expenses | 21.48 Billion | 19.23 Billion | 16.73 Billion | 15.92 Billion | 14.4 Billion | -3.93 Billion |
| Cost and Expenses | 795.97 Billion | 676.76 Billion | 482.13 Billion | 350.37 Billion | 412.04 Billion | 671.13 Billion |
| Operating Income | 3 Billion | 41.42 Billion | 30.48 Billion | 5 Billion | -10.89 Billion | 6.24 Billion |
| Interest Expense | 9.41 Billion | 7.3 Billion | 6.53 Billion | 8.48 Billion | 8.45 Billion | 8.05 Billion |
| Income Tax Expense | 598.31 Million | 4.54 Billion | 4.99 Billion | -3.22 Billion | -4.19 Billion | 137.54 Million |
| Earnings before Tax | -6.87 Billion | 36.01 Billion | 28.49 Billion | -18.84 Billion | -18.74 Billion | -8.7 Billion |
| Net Income | -26.82 Billion | 31.47 Billion | 23.5 Billion | -15.62 Billion | -14.54 Billion | -15.89 Billion |
| Earnings Per Share Basic | -753.82 | 918.19 | 736.47 | -513.83 | -635.28 | -745.26 |
| Earnings Per Share Diluted | -753.82 | 918.19 | 736.47 | -513.83 | -635.28 | -745.26 |
| Weighted Average Shares Outstanding | 35.58 Million | 34.27 Million | 31.91 Million | 30.4 Million | 22.89 Million | 21.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.58 Million | 34.27 Million | 31.91 Million | 30.4 Million | 22.89 Million | 21.32 Million |
| Gross Margin | 0.06 | 0.11 | 0.13 | 0.10 | 0.06 | 0.05 |
| EBIT Margin | 0.03 | 0.10 | 0.11 | 0.08 | 0.02 | 0.03 |
| Profit Margin | -0.03 | 0.04 | 0.05 | -0.04 | -0.04 | -0.02 |
| EBITDA | 27.48 Billion | 68.55 Billion | 58.55 Billion | 14.94 Billion | 16.84 Billion | 24.53 Billion |
| Earnings Before Tax Margin | 0.00 | 0.06 | 0.06 | 0.01 | -0.03 | 0.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 233.53 Billion | 159.73 Billion | 129.28 Billion | 798.98 Billion | 194.84 Billion | 240.66 Billion |
| Cost of Revenue | 218.12 Billion | 149.87 Billion | 128.93 Billion | 754.41 Billion | 178.77 Billion | 224.54 Billion |
| Gross Profit | 15.4 Billion | 9.85 Billion | 347.86 Million | 44.56 Billion | 16.06 Billion | 16.11 Billion |
| Operating Expenses | 11.19 Billion | 10.28 Billion | 9.63 Billion | 41.65 Billion | -11.51 Billion | -10.69 Billion |
| Selling, General and Administrative Expenses | 9.99 Billion | 9.16 Billion | 8.59 Billion | - | 11.51 Billion | 10.69 Billion |
| Research and Development Expenses | 1.02 Billion | 947.93 Million | 839.86 Million | - | 947.7 Million | 986.19 Million |
| Other Expenses | -171.87 Million | -179.94 Million | -203.6 Million | -880.5 Million | -23.03 Billion | -21.38 Billion |
| Cost and Expenses | 229.31 Billion | 160.16 Billion | 138.57 Billion | 796.06 Billion | 178.77 Billion | 224.54 Billion |
| Operating Income | 4.21 Billion | -429.15 Million | -9.28 Billion | 2.91 Billion | 4.55 Billion | 5.41 Billion |
| Interest Expense | 1.98 Billion | 2.57 Billion | 240.37 Million | 9.41 Billion | 2.75 Billion | 3.51 Billion |
| Income Tax Expense | 2.84 Billion | 724.77 Million | -4.09 Billion | 598.31 Million | 2.17 Billion | 1.7 Billion |
| Earnings before Tax | 499.37 Million | -2.11 Billion | -9.24 Billion | -5.96 Billion | 4.7 Billion | 468.82 Million |
| Net Income | -5.42 Billion | -6.67 Billion | -12.12 Billion | -26.82 Billion | -3.96 Billion | -5.22 Billion |
| Earnings Per Share Basic | -141.48 | -174.00 | -316.16 | - | -113.10 | -146.30 |
| Earnings Per Share Diluted | -141.48 | -174.00 | -316.16 | - | -113.10 | -146.30 |
| Weighted Average Shares Outstanding | 38.36 Million | 38.36 Million | 38.36 Million | 35.58 Million | 35.05 Million | 35.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.36 Million | 38.36 Million | 38.36 Million | 35.58 Million | 35.05 Million | 35.73 Million |
| Gross Margin | 0.07 | 0.06 | 0.00 | 0.06 | 0.08 | 0.07 |
| EBIT Margin | 0.05 | 0.04 | -0.02 | - | 0.08 | 0.07 |
| Profit Margin | -0.02 | -0.04 | -0.09 | -0.03 | -0.02 | -0.02 |
| EBITDA | 11.51 Billion | 6.94 Billion | -3.2 Billion | - | 16.06 Billion | 16.11 Billion |
| Earnings Before Tax Margin | 0.02 | -0.00 | -0.07 | 0.00 | 0.02 | 0.02 |
SNTE
PAP
SRP
ALTOO
ONCO
PMREF